KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Receivables (2016 - 2026)

Xylem has reported Receivables over the past 17 years, most recently at $1.8 billion for Q1 2026.

  • For Q1 2026, Receivables rose 59766.67% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $1.8 billion, up 59766.67%, while the annual FY2025 figure was $1.0 million, 99.94% down from the prior year.
  • Receivables for Q1 2026 was $1.8 billion at Xylem, up from $1.8 billion in the prior quarter.
  • Over five years, Receivables peaked at $1.8 billion in Q1 2026 and troughed at $1.0 million in Q3 2025.
  • A 5-year average of $811.1 million and a median of $1.0 billion in 2022 define the central range for Receivables.
  • Biggest five-year swings in Receivables: plummeted 99.82% in 2024 and later soared 59766.67% in 2026.
  • Year by year, Receivables stood at $1.1 billion in 2022, then skyrocketed by 47.99% to $1.6 billion in 2023, then increased by 2.84% to $1.7 billion in 2024, then rose by 5.46% to $1.8 billion in 2025, then grew by 2.1% to $1.8 billion in 2026.
  • Business Quant data shows Receivables for XYL at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.0 million in Q3 2025.